Tirzepatide weight-loss injection
Describe Tirzepatide and Describe the Workings of Our Program.
Tirzepatide injection is an agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor.
Weight loss from baseline to 40 treatment weeks revealed that Tirzepatide (5 mg, 10 mg, and 15 mg) provided at least 30%, 60%, and up to 95% more weight loss than Semaglutide (1 mg).
| QUANTITY | 0-5mg, 10.0mg, 15.0mg |
|---|
Reviews
There are no reviews yet.
Be the first to review “tirzepatide”